# Real-world availability of CAR T-cell therapies

Page: https://stenobird.com/podcast/blood-podcast-664776/real-world-availability-of-car-t-cell-therapies
Text version: https://stenobird.com/podcast/blood-podcast-664776/real-world-availability-of-car-t-cell-therapies.md
Podcast: [Blood Podcast](https://stenobird.com/podcast/blood-podcast-664776)
Published: 2026-04-16T16:33:22+00:00
Episode link: https://share.transistor.fm/s/1a6a718d
Audio file: https://prfx.byspotify.com/e/media.transistor.fm/1a6a718d/89e44675.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/real-world-availability-of-car-t-cell-therapies
Duration seconds: 598

## Resource

In this week's episode, Blood podcast editor Laurie Sehn interviews Drs. Edward Cliff on his latest research published in volume 147 issue 14 of Blood . Dr. Cliff discusses " Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries " which maps the mismatch between innovation and implementation across high-income and selected-upper-middle-income countries for US Food and Drug Administration–approved products and indications.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/real-world-availability-of-car-t-cell-therapies/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/blood-podcast-664776/real-world-availability-of-car-t-cell-therapies.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.